ライフサイエンスコーパス: catheter

1 ed RFA applications (30 Wx30 seconds, 3.5 mm catheter).

2 ron dose and vascular access (fistula versus catheter).

3 ing implantation of an indwelling peritoneal catheter.

4 adiofrequency energy from a 9-mm lattice-tip catheter.

5 medication, and presence of a central venous catheter.

6 lose to the transducer number 1 of the 3DHRM catheter.

7 formed using a conventional circular mapping catheter.

8 s, Abbott) was used to maneuver the ablation catheter.

9 21 LAPWs (100%) treated with the pentaspline catheter.

10 mferential location of the metal ball on the catheter.

11 s) occurred in peripherally inserted central catheters.

12 usion via surgically-implanted, intragastric catheters.

13 compared with peripherally inserted central catheters.

14 central catheters and 66,194 central venous catheters.

15 ntaRay, IntellaMap Orion, or Advisor HD Grid catheters.

16 nificantly higher than that of lower-density catheter (0.81+/-0.02 versus 0.66+/-0.04, P<0.05).

17 rted central catheter: 0.73%, central venous catheter: 0.24%; p = 0.001) (peripherally inserted centr

18 rted central catheter: 0.93%, central venous catheter: 0.52%; p = 0.001) (peripherally inserted centr

19 eam infection (peripherally inserted central catheter: 0.73%, central venous catheter: 0.24%; p = 0.0

20 romboembolism (peripherally inserted central catheter: 0.93%, central venous catheter: 0.52%; p = 0.0

21 %; p = 0.001) (peripherally inserted central catheter: 10.82/1,000 line days, central venous catheter

22 with persistent AF using 2 high-density grid catheters (16 electrodes, 3 mm spacing).

23 Survival curves for 360-degree catheter, 270-degree to 360-degree combined catheter/Har

24 heter: 10.82/1,000 line days, central venous catheter: 4.97/1,000 line days) occurred in peripherally

25 Lesions were created using the SERF catheter (40 W/50 degrees C) or a standard contact force

26 theter: 8.65/1,000 line days, central venous catheter: 6.29/1,000 line days) and central-line associa

27 %; p = 0.001) (peripherally inserted central catheter: 8.65/1,000 line days, central venous catheter:

28 : vasoactive infusions (88%), central venous catheters (86%), mechanical ventilation (59%), and high

29 The limited effectiveness of endocardial catheter ablation (CA) for persistent and long-standing

30 tral isthmus (MI) block using radiofrequency catheter ablation (RFCA) alone is challenging, and MI re

31 Patients were randomly assigned to catheter ablation alone (n = 158) or catheter ablation c

32 sion group compared with 38% (60/158) in the catheter ablation alone group (difference, 11.2% [95% CI

33 infusion to catheter ablation, compared with catheter ablation alone, increased the likelihood of rem

34 on added to catheter ablation, compared with catheter ablation alone, significantly increased the lik

35 model to estimate the costs and benefits of catheter ablation and medical management in patients wit

36 Either medical treatment or catheter ablation are considered first-line therapies in

37 e hypothesized that open irrigated microwave catheter ablation can create deep myocardial lesions end

38 evidenced by multiple randomized trials, AF catheter ablation can reduce the risk of recurrent AF an

39 gned to catheter ablation alone (n = 158) or catheter ablation combined with vein of Marshall ethanol

40 a single procedure was 49.2% (91/185) in the catheter ablation combined with vein of Marshall ethanol

41 AF burden was significantly less in catheter ablation compared with drug-therapy patients ac

42 The incremental cost-effectiveness ratio for catheter ablation compared with medical management was $

43 factors of esophageal injury (EI) caused by catheter ablation for AF.

44 The optimal timing of catheter ablation for atrial fibrillation (AF) in refere

45 Catheter ablation for atrial fibrillation (AF) using poi

46 edisposes esophagus to thermal injury during catheter ablation for atrial fibrillation (AF).

47 mized clinical trials have demonstrated that catheter ablation for atrial fibrillation in patients wi

48 udies reporting the outcomes associated with catheter ablation for atrial fibrillation stratified by

49 t failure admissions in the CASTLE-AF study (Catheter Ablation for Atrial Fibrillation With Heart Fai

50 ighly morbid condition that can result after catheter ablation for PV isolation.

51 emerged, sometimes used in combination with catheter ablation for the treatment of the atrial fibril

52 Catheter ablation for ventricular tachycardia (VT) reduc

53 .001) were both significantly reduced in the catheter ablation group.

54 Catheter ablation in patients with heart failure with re

55 idence on the long-term clinical benefits of catheter ablation in patients with persistent atrial fib

56 Catheter ablation is an increasingly used treatment for

57 l of one or more antiarrhythmic drugs before catheter ablation is considered in patients with atrial

58 Catheter ablation is increasingly used as a first-line t

59 lation that has not responded to medication, catheter ablation is more effective than antiarrhythmic

60 the pulmonary veins from the left atrium by catheter ablation is superior to antiarrhythmic drug the

61 Catheter ablation is the most efficacious approach to er

62 Irrigated microwave catheter ablation may be an effective ablation modality

63 al trial conducted at 5 referral centers for catheter ablation of atrial fibrillation in the Russian

64 paroxysmal atrial fibrillation who underwent catheter ablation of paroxysmal atrial fibrillation.

65 Catheter ablation of persistent atrial fibrillation (AF)

66 ion of systolic dysfunction after successful catheter ablation of PVCs demonstrates that a causal rel

67 localizing the origin of arrhythmias during catheter ablation of ventricular tachycardia (VT) in str

68 During catheter ablation of VT, simultaneous mapping was perfor

69 ervative estimate of the treatment effect of catheter ablation on mortality (hazard ratio of 0.86), t

70 were the cost of ablation and the effect of catheter ablation on mortality reduction.

71 04 patients with atrial fibrillation (AF) to catheter ablation or drug therapy.

72 l tachycardia) between 91 and 365 days after catheter ablation or the initiation of an antiarrhythmic

73 AF burden was also significantly reduced in catheter ablation patients, regardless of their baseline

74 In 19 patients undergoing 21 catheter ablation procedures of scar-related VT, site of

75 he Evaluate Renal Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERAD

76 Twelve patients (15%) underwent safe catheter ablation under venoarterial extracorporeal memb

77 The CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for

78 (Catheter Ablation vs Anti-arrhythmic Drug Therapy for At

79 Catheter ablation was associated with 6.47 (95% CI, 5.89

80 Catheter ablation was effective in reducing recurrence o

81 al, untreated atrial fibrillation to undergo catheter ablation with a cryothermy balloon or to receiv

82 discrete radiofrequency lesion delivery via catheter ablation without concomitant use of an electroa

83 and hypertension, renal denervation added to catheter ablation, compared with catheter ablation alone

84 tion of vein of Marshall ethanol infusion to catheter ablation, compared with catheter ablation alone

85 Despite the existing data on AF catheter ablation, numerous knowledge gaps remain concer

86 ation time (DAT), on AF recurrence following catheter ablation.

87 ic drug levels are reached to safely perform catheter ablation.

88 d to recurrent ventricular tachycardia after catheter ablation.

89 ction of patient-centered outcomes following catheter ablation.

90 ith paroxysmal atrial fibrillation receiving catheter ablation.

91 r hemodynamic instability prevents emergency catheter ablation.

92 Using the focal PFA catheter, acute cavotricuspid isthmus block was achieved

93 ds ratio, 0.13; 95% CI, 0.1-0.2) and urinary catheter (adjusted odds ratio, 0.28; 95% CI, 0.1-0.6).

94 h the internal geometry of the vessel as the catheter advances through the vasculature.

95 lts and to explore implementation of earlier catheter AF ablation and patient outcomes within the cur

96 (IVUS) and near-infrared spectroscopy (NIRS) catheter after successful PCI of all flow-limiting coron

97 acutely successful with the multispline PFA catheter alone.

98 Patients monitored by an esophageal catheter and a 32-electrode electrical impedance tomogra

99 tion was confirmed with the circular mapping catheter and a post ablation voltage map.

100 ribution of microorganisms in central venous catheter and arterial catheter-related bloodstream infec

101 septum puncture, with irrigated conventional catheter and electroanatomic reconstruction.

102 -Fc (n = 8) delivered via intrathecal lumbar catheter and osmotic minipump for 4 months.

103 investigated in 25 swine using a lattice-tip catheter and system (Affera Inc).

104 are associated with time on a central venous catheter and transition to an arteriovenous fistula and

105 ncluding 4,493 peripherally inserted central catheters and 66,194 central venous catheters.

106 ces, including peripherally inserted central catheters and central venous catheters, are often needed

107 Magnetically steered catheters and continuum manipulators also suffer from li

108 Magnetic steering of catheters and continuum manipulators is another technolo

109 ized with isofluorane and maternal and fetal catheters and flow probes were implanted to determine ca

110 /-9 years) were recorded with 64-pole basket catheters and simultaneous 57-lead body surface ECGs.

111 d 8 PFA applications/site (2 kV, multispline catheter), and 4 animals received 6 clusters of irrigate

112 ns of how guidewires, insulation, adjunctive catheters, and dielectric medium interact.

113 positive for LVO (n = 270) were confirmed by catheter angiography and LVO-negative examinations (n =

114 kground Paclitaxel drug-coated balloon (DCB) catheter angioplasty is the preferred treatment for reva

115 Peripherally inserted central catheters are associated with higher rates of central-li

116 f artificial urine medium, while the control catheters are blocked by UPEC biofilms within 5 days.

117 Tunneled peritoneal drainage catheters are described as an effective and relatively s

118 plantable electronic devices, and indwelling catheters are effectively evaluated with echocardiograph

119 s because serious complications can arise if catheters are malpositioned.

120 Catheters are the second most common abnormal finding on

121 nserted central catheters and central venous catheters, are often needed in critically ill patients,

122 of deep learning approaches, the problem of catheter assessment is far more solvable.

123 PICC) line and its effectiveness in reducing catheter associated thrombosis and pathogen colonization

124 and repeated life-threatening central venous catheter-associated infections requiring critical care.

125 tions allow antibiotic-mediated clearance of catheter-associated S. Typhimurium biofilms.

126 the vague symptoms that most commonly define catheter-associated urinary tract infection (CAUTI) and

127 m-negative uropathogen and frequent cause of catheter-associated urinary tract infection (CAUTI).

128 PPD) for all nursing personnel and number of catheter-associated urinary tract infections (CAUTI) and

129 of colonization, resulting in false positive catheter-associated urinary tract infections (CAUTI).

130 females; over half (54%) were reported from catheter-associated urinary tract infections.

131 isk neutropenia, or patients with indwelling catheters at the time of catheter removal.

132 were also calculated from experiments with a catheter balloon embedded in a plastisol phantom at mult

133 cted aortic valves that require replacement, catheter-based bioprosthetic valve deployment offers a m

134 icability and therapeutic efficacy of local, catheter-based delivery of antimiR-21 in a pig model of

135 fers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pre

136 h the MitraClip, and there are several novel catheter-based percutaneous options in clinical trials.

137 skin and, in certain instances, can involve catheter-based pressure sensors inserted into the arteri

138 lization is a life-saving minimally invasive catheter-based procedure performed to treat bleeding ves

139 In catheter-based procedures, acute kidney injury (AKI) is

140 SPYRAL Pivotal showed the superiority of catheter-based renal denervation compared with a sham pr

141 Catheter-based renal denervation has significantly reduc

142 this work, we report on the development of a catheter-based sensor designed for measuring the concent

143 New treatments, such as catheter-based therapies, require further testing to ide

144 lectomy, and a growing number of options for catheter-based therapy.

145 tes to the thrombolytic treatment as well as catheter-based treatment, and results from recent trials

146 The Bashir Endovascular Catheter (BEC) is a novel pharmaco-mechanical device des

147 the existing right subclavian vein dialysis catheter because of stenosis in the superior vena cava.

148 rTM was administered into the jugular-vein catheter before or 6 h after MRSA inoculation, while an

149 samples were collected from the jugular-vein catheter before, 6 h and 12 h after MRSA inoculation.

150 luded studies concerning indwelling vascular catheters, blood sampling, combination antiseptics or se

151 udy because of surgical complications of the catheter, but no treatment-related adverse events were n

152 The lattice-tip catheter can deliver focal PF to durably isolate veins a

153 ilayer configurations on endocardial balloon catheters can establish conformal contact with curved ti

154 e injection site and accumulation in central catheters can lead to limited tumor (18)F-FDG uptake, er

155 Among central venous catheter catheter-related bloodstream infection, nonferm

156 ith sinus venosus defects to be eligible for catheter closure.

157 ne-enhanced radiofrequency (SERF) needle-tip catheter, compared with a conventional ablation catheter

158 rom patients or controls through ventricular catheters connected to subcutaneous osmotic pumps.

159 A novel lattice-tip catheter could safely and rapidly ablate atrial fibrilla

160 ngs from conventional pulmonary vein mapping catheters could achieve similar results.

161 The SERF catheter created more transmural and larger ablative les

162 rate of atrial fibrillation recurrence with catheter cryoballoon ablation than with antiarrhythmic d

163 tates start hemodialysis on a central venous catheter (CVC).

164 ajority of cases secondary to central venous catheters (CVCs).

165 ms associated with the use of central venous catheters (CVL).

166 the binary classification of higher-density catheter data set was significantly higher than that of

167 was reduced by 77% (6.6 to 1.5), CAUTI/1000-catheter days by 63% (5.9 to 2.2) and urinary catheter d

168 ly reduced CAUTI infection rates and urinary catheter days.

169 atheter days by 63% (5.9 to 2.2) and urinary catheter days/patient by 37% (1.1 to 0.69, all P<=0.001)

170 versus 57% at the control campus, CAUTI/1000 catheter-days declined by 68% versus 57% and catheter-da

171 catheter-days declined by 68% versus 57% and catheter-days/patient decreased by 44% versus 1% (all P<

172 The value of CT for catheter-delivered valve implantation (eg, transcatheter

173 denervation using an irrigated-tip ablation catheter delivering radiofrequency energy to discrete si

174 de convection-enhanced delivery, alternative catheter delivery, and neuro-surgically applied delivery

175 We retrospectively identified 300 catheter-dependent patients on hemodialysis with a new A

176 This study investigated a novel lattice-tip catheter designed for focal RFA or PFA ablation.

177 al and proximal thirds (P = 0.04) and a mean catheter diameter-to-OA lumen ratio of 0.6 or more (P <

178 Esophageal stimulation via a special feeding catheter did not improve nutritional adequacy and was as

179 dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis improve short-term comput

180 dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis in the OPTALYSE-PE trial

181 ose tPA regimens for ultrasound-facilitated, catheter-directed fibrinolysis resulted in sustained rec

182 Catheter-directed fibrinolysis with or without mechanica

183 imaging parameters among patients undergoing catheter-directed thrombolysis for submassive or massive

184 e greatest benefit from ultrasound-assisted, catheter-directed thrombolysis.

185 patient selection for ultrasound-facilitated catheter-directed thrombolysis.

186 ographic index following ultrasound-assisted catheter-directed thrombolysis.

187 Intermediate Coronary Stenosis With Guiding Catheter Disengagement) registry, FFR was prospectively

188 Colonized arterial catheters due to nonfermenting Gram-negative bacilli wer

189 al stimulation via an esophageal stimulating catheter (E-Motion Tube; E-Motion Medical, Tel Aviv, Isr

190 through sequential mapping with a multipolar catheter effectively achieved an ablation response in al

191 3D high-resolution manometry (3DHRM) with a catheter equipped with 96 transducers (for the EGJ press

192 d relatively primitive modes of operation of catheters equipped with sensing or actuation elements im

193 d larger lesion volumes than the standard CF catheter-even with >20 g of CF-in both normal (983.1+/-9

194 Selective intrarenal artery catheters facilitate direct delivery of short acting vas

195 PFA using a lattice-tip ablation catheter for focal ablation produced durable atrial lesi

196 ng biphasic, bipolar PFA using a multispline catheter for PVI and LAPW ablation under intracardiac ec

197 g radiographs with potentially malpositioned catheters for interpretation and automatically insert te

198 ating advanced electronic functionality with catheters for minimally invasive forms of cardiac surger

199 anned proton beams can be used as a tool for catheter-free ablation, and time-course of tissue apopto

200 c patients with cancer with a central venous catheter from April 2015 to August 2019 at a single site

201 surement, the simple presence of the guiding catheter (GC) within the coronary ostium might create ar

202 arteriovenous fistula, those doing so via a catheter had a higher incidence of having any infection,

203 In multivariable analysis, central venous catheters had decreased association with central-line as

204 catheter, 270-degree to 360-degree combined catheter/Harms trabeculotome, and <180-degree Harms trab

205 The development of multielectrode mapping catheters has expanded the spectrum of mappable ventricu

206 One-shot PFA catheters have been developed for pulmonary vein isolati

207 One-shot PFA catheters have been shown capable of performing pulmonar

208 degrees C) or a standard contact force (CF) catheter in both groups.

209 heter, compared with a conventional ablation catheter in normal and infarcted myocardium.

210 ure safe implantation and positioning of the catheter in those cases.

211 d venous thromboembolism than central venous catheters in children admitted to the PICU.

212 ally insert text indicating the placement of catheters in radiology reports, thereby improving radiol

213 The use of multielectrode mapping catheters in recording diastolic activity may help predi

214 of Aortic Valve Bioprostheses Established by Catheter) included 12 141 patients undergoing BE-THV (Ed

215 sufficient for mature biofilm formation and catheter infection.

216 The proportion of intravascular catheter infections due to nonfermenting Gram-negative b

217 rom fMRI during urodynamic studies driven by catheter infusion of fluid into the bladder.

218 g upright ergometry, while using conductance catheters inserted into the RV to generate real-time PV

219 prospective high-quality data collection at catheter insertion and catheter removal was performed.

220 Freedom from surgical and catheter interventions and reinterventions was compared.

221 ] years) and had lower freedom from surgical/catheter interventions compared with patients with WBS,

222 aches, lifestyle modifications, surgical and catheter interventions, and medications that constitute

223 raphies (1-week washout), with an epiglottic catheter, intramuscular genioglossus electromyography, n

224 Based on these findings, a prototype catheter is engineered and found to remain clean for at

225 SERF catheter lesions were more often transmural than standar

226 es, deaths, or peripherally inserted central catheter-line complications were reported.

227 ciated bloodstream infections (CLABSIs), and catheter malfunctions in PICCs and TLs, and risk factors

228 Using the SERF catheter, mean depth of ablated lesions reached 90% of t

229 a critical factor for infection using a rat catheter model.

230 The position of catheters must be assessed on all radiographs because se

231 Through these catheters, numerous metallic coils are often pushed into

232 Paraplegia after epidural catheter occurred once.

233 ter-aided diagnosis system for assessment of catheters on radiographs.

234 eterization with a short-term central venous catheter or peripheral arterial catheter with an expecte

235 who had a contraindication to an esophageal catheter or respiratory inductance plethysmography bands

236 r removal prior to urine sampling from a new catheter or sterile straight catheterization, along with

237 tion for patients with cirrhosis, indwelling catheters, or undergoing peritoneal dialysis.

238 modynamic monitoring with a pulmonary artery catheter (PAC).

239 our days prior to presentation, her dialysis catheter (Palindrome; Medtronic, Mannsfield, Mass) was p

240 tients, patients with an indwelling urethral catheter, patients with impaired voiding following spina

241 Area of trans-catheter perfusion dynamically quantified on representat

242 crocatheter proximally to rete allowed trans-catheter perfusion of the ipsilateral hemisphere as visu

243 ocarbon-coated peripherally inserted central catheter (PICC) line and its effectiveness in reducing c

244 the number of peripherally inserted central catheters (PICCs) placed has risen significantly.

245 on during distal CS pacing with a deca-polar catheter placed with its proximal electrode at the ostiu

246 f 2 IRE applications with slightly different catheter positions were delivered per vein to achieve ci

247 Comparing SERF to CF ablation, the SERF catheter produced larger lesion volumes than the standar

248 rial fibrillation (AF) ablation using basket catheters recently showed high rates of AF termination a

249 A catheter reintervention was required in 11.8% and surger

250 Catheter reinterventions can avoid the need for surgery

251 stribution of microorganisms associated with catheter-related bloodstream infection and colonization

252 still associated with an increased risk for catheter-related bloodstream infection due to nonferment

253 al therapy should be considered if a femoral catheter-related bloodstream infection is suspected.

254 isms in central venous catheter and arterial catheter-related bloodstream infections and colonization

255 No patient had central venous catheter-related deep vein thrombosis.

256 hs (1 month in children <2 years of age with catheter-related venous thromboembolism).

257 Cs, which had a significantly higher risk of catheter-related VTE than subjects with TLs (hazard rati

258 ICCs had a significantly higher incidence of catheter-related VTE, CLABSI, and CVC malfunction over T

259 pus implemented a protocol requiring urinary catheter removal prior to urine sampling from a new cath

260 ty data collection at catheter insertion and catheter removal was performed.

261 nts with indwelling catheters at the time of catheter removal.

262 We have validated the catheter sensor on human intestinal liquids spiked with

263 nutrition may lead to complications such as catheter sepsis and metabolic diseases.

264 romboresistance than fluorinated, omniphobic catheter surfaces, produced by previously reported self-

265 Future applications could be catheters tailored to cardiovascular, urological, gastro

266 Among central venous catheter, the distribution of microorganisms associated

267 Among colonized arterial catheters, the distribution of microorganisms was signif

268 ssues to streamline safer deployment through catheters, the impact of such tissues in the complex, me

269 modialysis treatment via the newly exchanged catheter.The patient denied trauma prior to the swelling

270 olation using a contact force radiofrequency catheter (Thermocool SmartTouch, Biosense Webster, Inc,

271 ing an occlusive procedure, placement of the catheter tip into the OA distal third versus medial and

272 Electrodes near the catheter tip simultaneously create a weak electric field

273 Bronchial rheoplasty uses an endobronchial catheter to apply nonthermal pulsed electrical fields to

274 ximum 60 mg per instillation) via retrograde catheter to the renal pelvis and calyces.

275 d, it can be easily delivered using clinical catheters to embolize renal and iliac arteries, and it c

276 divide these techniques into those that use catheters to occlude straight saphenous axes (thermal /

277 A 360-degree catheter trabeculotomy is highly effective in obtaining

278 Obviate Lung Injury], and FACTT [Fluids and Catheter Treatment Trial]; n = 2,022), and a fourth serv

279 All patients were fed via these catheters using a standardized feeding protocol.

280 In addition, exchange of the dialysis catheter via guidewire was performed, without any report

281 en echocardiography and the pulmonary artery catheter was moderate (Cohen's Kappa, 0.48; 95% CI, 0.39

282 Commercially available polyurethane PICC catheter was modified by a three-step lamination process

283 ither a circular or basket electrophysiology catheter was placed in the right pulmonary artery to all

284 within 1 year prior; or if a central venous catheter was present <=2 days prior.

285 A focal PFA catheter was used for cavotricuspid isthmus ablation.

286 -arm, first-in-human trial, the 7.5F lattice catheter was used with a custom mapping system to treat

287 rly ambulation, and early removal of urinary catheter) was implemented in five academic and community

288 A pressure probe and a microdialysis catheter were placed intradurally at the injury site to

289 A total of 7,235 patients and 15,259 catheters were included.

290 oral arterial access, high fidelity pressure catheters were placed in the left ventricle and aortic r

291 ures, 53 new AVFs, and 50 temporary dialysis catheters were required.

292 designed and constructed irrigated microwave catheters were tested in in vitro phantom models and in

293 A novel lattice-tip ablation catheter with a compressible 9-mm nitinol tip is able to

294 ondeflectable 14-polar circular IRE ablation catheter with a variable hoop diameter (16-27 mm).

295 ntral venous catheter or peripheral arterial catheter with an expected duration of use of more than 4

296 ine concentrations in vivo, a nasointestinal catheter with histamine-sensing capabilities has the pot

297 s from a newly designed electrogenic sensory catheter with preoperative imaging to provide continuous

298 e contrast medium was administered through a catheter with the tip placed 2 cm below the aortic bifur

299 oughput process of modifying commercial PICC catheters with fluoropolymer is quicker, safer and shows

300 el to determine the relative position of the catheter within the vessel tree.